Pulmonary Disease, Chronic Obstructive Clinical Trial
Official title:
Efficacy of Acupuncture in Exercise Tolerance in Patients With COPD Controlled, Randomized, Double Blind Study
Verified date | December 2018 |
Source | Instituto de Ciências Biomédicas Abel Salazar |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic Obstructive Pulmonary Disease (COPD) is nowadays the 4th cause of death in the world
and it´s expected to become the 3rd cause of death in 2020 and the majority cause of
morbidity. Besides that, in Portugal COPD patients become more dependents each day.
Acupuncture as a reflex therapy it´s carried out through a Traditional Chinese Medicine (TCM)
diagnose that will allowed to identify the acupoints.
The investigators are interested in to assess acupuncture efficacy on physical exercise
tolerance in COPD patients.An experimental, controlled, randomized, double blind study was
done. Patients were recruited according TCM diagnose to optimize potential therapeutic
effects.
Status | Completed |
Enrollment | 29 |
Est. completion date | November 28, 2018 |
Est. primary completion date | September 25, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - COPD GOLD III,IV; - able to walk; - Informed consent signed; - stable medication during last 3 days - exacerbation during 3 months; - Chinese diagnose opening principle; - blood pressure "90"180 mmhg/ "100mmhg; respiratory rate "10"30 cpm Exclusion Criteria: - smoker; - metastasis; - hepatic, - renal or cardiovascular disease; - pulmonary hypertension; - COPD symptoms exacerbation during the therapy; - previous acupuncture treatments; - unstable vital signs; - pulmonary rehabilitation in the last 6 months; - needle phobia. |
Country | Name | City | State |
---|---|---|---|
Portugal | Carla Manuela Loureiro Barros | Marco de Canaveses | Porto |
Lead Sponsor | Collaborator |
---|---|
Instituto de Ciências Biomédicas Abel Salazar |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | six minute walk test (6MWT) | distance walked (metres) | 6 minutes | |
Secondary | Oxygen peripheral saturation (SPO2) | pulse oximeter | 6 minutes | |
Secondary | Rating of perceived exertion (Borg Scale) | during 6MWT | 6 minutes | |
Secondary | Blood pressure | measure at end of 6MWT | 6 minutes | |
Secondary | heart rate | at end of 6MWT | 6 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|